Back to products
Next product
Stelara (ustekinumab)
CHF16,833.70
Libtayo (cemiplimab)
CHF3,828.00
Libtayo (cemiplimab) is a medication used for the treatment of advanced cutaneous squamous cell carcinoma (CSCC), advanced basal cell carcinoma (BCC) and advanced non-small cell lung cancer (NSCLC).
Reviews
There are no reviews yet.